T
56
2
ADI
59
-2
GM
58
-2
TGT
50
-2
GME
63
12
EXC
53
6
TAP
45
-6
WU
12
-4
MCHP
43
-6
DTE
63
7
CHK
48
15
ALLE
57
-7
L
55
-4
FIS
46
-4
HSIC
50
-3
BWA
45
-4
UNH
53
-3
C
60
-2
ILMN
41
-3
DOV
64
-5
T
56
2
ADI
59
-2
GM
58
-2
TGT
50
-2
GME
63
12
EXC
53
6
TAP
45
-6
WU
12
-4
MCHP
43
-6
DTE
63
7
CHK
48
15
ALLE
57
-7
L
55
-4
FIS
46
-4
HSIC
50
-3
BWA
45
-4
UNH
53
-3
C
60
-2
ILMN
41
-3
DOV
64
-5
Financhill
Back

Citigroup Vs. Apellis Pharmaceuticals Industry Stock Comparison

Buy
60

C
Citigroup

Last Price:
62.12
Seasonality Move:
0.8%
Sell
19

APLS
Apellis Pharmaceuticals

Last Price:
32.49
Seasonality Move:
18.8%
Buy
60
Citigroup (C) is a Buy

Is Citigroup a Buy, Sell or Hold?

  • The current Citigroup [C] share price is $62.14. The Score for C is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
  • C is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
19
Apellis Pharmaceuticals (APLS) is a Sell

Is Apellis Pharmaceuticals a Buy, Sell or Hold?

  • The current Apellis Pharmaceuticals [APLS] share price is $32.50. The Score for APLS is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
  • APLS is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

C Stock Price Chart

What is Citigroup's stock price today?

  • The Citigroup share price today is $62.14
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and C is experiencing slight selling pressure.

APLS Stock Price Chart

What is Apellis Pharmaceuticals's stock price today?

  • The Apellis Pharmaceuticals share price today is $32.50
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and APLS is experiencing slight selling pressure.

C Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.14 Sell
Relative Strength Index (14 RSI): 57.73 Buy
Chaikin Money Flow: -793365 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (58.79 - 62.17) Buy
Bollinger Bands (100): (59.41 - 64.45) Buy

APLS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.84 Sell
Relative Strength Index (14 RSI): 33.6 Sell
Chaikin Money Flow: -1084788 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (36.37 - 40.01) Sell
Bollinger Bands (100): (36.55 - 42.35) Sell

C Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 59.38 Buy
20-day SMA: 60.32 Buy
50-day SMA: 61.33 Buy
200-day SMA: 58.81 Buy
8-day EMA: 60.39 Buy
20-day EMA: 60.17 Buy
50-day EMA: 60.81 Buy
200-day EMA: 58.23 Buy

APLS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 36.19 Sell
20-day SMA: 38.04 Sell
50-day SMA: 37.88 Sell
200-day SMA: 50 Sell
8-day EMA: 35.96 Sell
20-day EMA: 37.21 Sell
50-day EMA: 38.25 Sell
200-day EMA: 45.7 Sell

Citigroup Earnings Growth & C Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.17 per share, an increase next quarter of $0.40 per share, an increase this year of $0.21 per share, and an increase next year of $1.33 per share.

Apellis Pharmaceuticals Earnings Growth & APLS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.74 per share, an increase next quarter of $0.23 per share, an increase this year of $3.28 per share, and an increase next year of $1.34 per share.

Citigroup Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Apellis Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):